- Anxiety & Depression
- Bipolar Disorder
- Dementia
- Depression
- Epilepsy
- Headache
- Movement Disorder
- Multiple Sclerosis
- Neuropathic Pain
- Psychiatry
- Psychosis
- Stroke
Our Publications
- DSM Dilemma: Issue 5
- DSM Dilemma: Issue 4
- DSM Dilemma: Issue 3
- DSM Dilemma: Issue 2
- DSM Dilemma: Issue 1
- Bright Times: Issue 4
- Mind Matters (Issue 4) - Effective Management of Comorbid Depression and Hypertension: Role of Escitalopram
- Bright Times: Issue 3
- Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes
- Bright Times: Issue 2
- Mind Matters (Issue 2) - Relationship between Depression and Cosmetic Problems: Role of Escitalopram
- Bright Times: Issue 1
- Mind Matters (Issue 1) – Escitalopram: Depression associated with Stroke
- Vilazodone (Vilarest) Monograph
Key Trials
Patient Education
Clinical Tools
Guidelines
- AHA/ASA: Management of Post-stroke Depression (2016)
- ACP: Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients with Major Depressive Disorder: A Clinical Practice Guideline (2016)
- ICSI: Depression, Adult in Primary Care (2016)
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015)
- WFSBP: Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder (2015)
- AACAP: Practice Parameter for the Assessment and Treatment of Children and Adolescents with Obsessive-Compulsive Disorder (2012)
- CANMAT: Recommendations for the Management of Patients With Mood Disorders And Comorbid Anxiety Disorders (2012)
- APA: Major Depressive Disorder: Practice Guidelines (2010)
- APA: Panic Disorder: Practice Guidelines (2009)
- BAP: Evidence-based Guidelines for Treating Depressive Disorders with Antidepressants (2008)
- WFSBP: Consensus Paper on Biological Markers in Depression (2007)
- WFSBP: Treatment Guidelines on Unipolar Depressive Disorder (2007)
- BAP: Evidence-based Guidelines on Pharmacological Treatment of Anxiety, Disorders (2005)
- NICE: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder: Clinical Guidelines (2005)
- NICE: Guidelines for Management of Anxiety (panic disorder, with or without agoraphobia and generalised anxiety disorder) in Adults in Primary Secondary and Community Care (2004)
Our Publications
Clinical Tools
Guidelines
- CANMAT/ISBD: Management of Patients with Bipolar Disorder - An Update (2018)
- BAP: Treatment of Bipolar Disorder (2016)
- BAP: Evidence-based Guidelines for Treating Bipolar Disorder: Revised 3rd Edition (2016)
- CANMAT/ ISBD: Guidelines for the Management of Patients with Bipolar Disorder: An Update (2013)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Attention-deficit/Hyperactivity Disorder (2012)
- CANMAT: Recommendations for the Management of Patients With Mood Disorders And Comorbid Anxiety Disorders (2012)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Medical Conditions: Diagnostic Assessment and Treatment Principles (2012)
- CANMAT: Recommendations for the Management of Patients with Mood Disorders And Comorbid Substance Use Disorders (2012)
- AACAP: Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents (2011)
- WFSBP: Guidelines on Biological Treatment of Acute Bipolar Depression: An Update (2010)
- CANMAT/ISBD: Guidelines for the Management of Patients With Bipolar Disorder: An Update (2009)
- AACAP: Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents (2009)
- CANMAT: Guidelines for the Management of Patients with Bipolar Disorder: Consensus and Controversies (2005)
Our Publications
Conference Proceedings
Patient Education
Clinical Tools
Guidelines
- AHA: Impact of Hypertension on Cognitive Function (2016)
- NICE: MID-Life Approaches to Delay or Prevent Onset of Dementia, Disability and Frailty (2015)
- Alzheimer’s Association: Recommendations for Operationalizing the Detection of Cognitive Impairment During the Medicare Annual Wellness Visit in a Primary Care Setting (2013)
- AAN: Evaluation and Management of Driving Risk in Dementia: An Update (2012)
- NIA-Alzheimer’s Association: New Diagnostic Criteria and Guidelines for Alzheimer's Disease (2011)
- WFSBP: Treatment Guidelines on Dementia (2011)
- BAP: Clinical Practice with Anti-Dementia Drugs (2010)
- APA: Alzheimer’s Disease and Other Dementias: Practice Guidelines (2007)
Patient Education
Our Publications
- Mind Matters (Issue 5) – Depression and Epilepsy: The Bidirectional Relationship
- Treatment with Valproate in Females with Epilepsy: Recommendations from ILAE and EAN
- Reduction of Febrile Seizure Recurrence by Oral Levetiracetam
- Epilepsy Times - Issue 8 : Epilepsy and Psychiatric Comorbidity: Emphasis on Lamotrigine
- Epilepsy Times - Issue 7: Prophylactic Anticonvulsants for Post Traumatic Epilepsy (PTE): Role of Levetiracetam
- Epilepsy Times - Issue 6: Newer Anticonvulsants in Patients with Dementia
- Epilepsy Times - Issue 5: Post-stroke Seizures and Post-stroke Epilepsy: Exploring Levetiracetam
- Epilepsy Times - Issue 4: Clinical Tool for Dosage Adjustment of Lamotrigine: Before, During and After Pregnancy
- Epilepsy Times - Issue 3: Levetiracetam Monotherapy in Patients with Brain Tumor Related Epilepsy (BTRE)
- Epilepsy Times - Issue 2: Exposure to Lamotrigine Monotherapy during Pregnancy is Safe: Results from 18 Years of International Lamotrigine Pregnancy Registry
- Levetiracetam in Idiopathic Generalized Epilepsy
- Epilepsy Times - Issue 1: Oxcarbazepine and Epilepsy
- Levetiracetam: Optimal Pharmacological Management of Partial Seizures
Key Trials
- EcLiPSE: Levetiracetam May Be Preferred Over Phenytoin as Second-line Treatment for Pediatric Convulsive Status Epilepticus
- Midazolam Nasal Spray vs. Diazepam Rectal Solution for Treating Seizure Exacerbations in Adults
- NEAD Study: Fetal Exposure to Antiepileptic Medications and Its Impact on IQ and Cognitive Outcomes at Age 6 Years
- SANAD Arm B: Valproate-The First Line Treatment for Generalized as well as Unclassified Seizures
- SANAD Arm A: Efficacy of Newer Antiepileptic Drugs Including Lamotrigine vs. Carbamazepine in Patients with Partial Onset Seizures
Conference Proceedings
Patient Education
Clinical Tools
Guidelines
- AES: New Guideline for Treatment of Prolonged Seizures in Children and Adults (2016)
- AES: Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults (2016)
- AAN: Evidence-based Guideline: Management of an Unprovoked First Seizure in Adults (2015)
- AAN: Vagus Nerve Stimulation for the Treatment of Epilepsy: An Update (2013)
- AAN: Medical Treatment of Infantile Spasms: An Update (2012)
- AAN: Evidence Based Guideline on the Selection of Antiepileptic Drugs for Patients With HIV/AIDS: Summary (2012)
- NICE: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care (2012)
- ILAE: New Concepts in Classification of the Epilepsies: Entering the 21st Century (2011)
- AAN: Practice Guidelines for Management Issue for Women with Epilepsy-Focus on Pregnancy; Teratogenesis and Perinatal Outcomes: An Update (2009)
- AAN: Practice Guidelines for Management Issues for Women with Epilepsy - Focus On Pregnancy; Obstetrical Complications and Change in Seizure Frequency: An Update (2009)
- AAN: Practice Guidelines for Management Issues for Women with Epilepsy - Focus On Pregnancy; Vitamin K, Folic Acid, Blood Levels , and Breastfeeding: An Update (2009)
- ILAE: Revised Terminology and Concepts for Epilepsies (2005–2009)
Our Publications
Conference Proceedings
Patient Education
Guidelines
- AAN/AHS: Acute Treatment of Migraine in Children and Adolescents - An Update (2019)
- AAN/AHS: Pharmacologic Treatment for Pediatric Migraine Prevention (2019)
- AHS: Position Statement on Integrating New Migraine Treatment into Clinical Practice (2019)
- ICSI: Diagnosis and Treatment of Headache (2013)
- International Classification of Headache Disorders (2013)
- IHS: Guideline on Headache Classification (2013)
- AAN & AHS: Guidelines for the Pharmacologic Prevention of Episodic Migraine in Adults: An Update (2012)
- BASH: Guidelines for the Diagnosis and Management of Migraine, Tension-Type headache, Cluster Headache & Medication Overuse Headache (2010)
- EFNS: Guidelines on the Drug Treatment of Migraine: Report (2009)
- SIGNS: Guidelines for the Diagnosis and Management of Headache in Adults (2008)
Patient Education
Guidelines
- AAN: Evaluation, Diagnosis and Management of Facioscapulohumeral Muscular Dystrophy (2015)
- AAN: Evidence Based Guidelines for Tardive Syndromes (2013)
- AAN: Practice Guidelines for the Pharmacological Treatment of Chorea in Huntington Disease (2012)
- AAN: Evidence Based Guidelines for Treatment of Essential Tremors (2011)
- MDS-ES & EFNS: Collaboration Guidelines on Dystonia (2011)
- AAN: Evidence Based Guidelines for Treatment of Nonmotor symptoms of Parkinson's disease (2010)
Key Trials
- Dimethyl Fumarate Associated with better Work Productivity Outcomes Over β Interferon and Glatiramer Acetate Therapies in RRMS Patients
- Dimethyl Fumarate Better than Teriflunomide and as Good as Fingolimod in MS
- Delayed-Release Dimethyl Fumarate Favorably Impacts MRI Parameters in RRMS Patients with Sustained Benefits till 2 Years
- Oral Dimethyl Fumarate-A Potential Initial Treatment for Relapsing-Remitting Multiple Sclerosis
Guidelines
- NICE: Assessment and Management of Low Back Pain and Sciatica in Patients Aged 16 Years and Above (2016)
- AAN/AANEM/AAPM&R: Practice Guidelines on Treatment of Painful Diabetic Neuropathy (2011)
- EFNS: Guidelines on Neuropathic Pain Assessment (2010)
- EFNS: Guidelines on the Pharmacological Treatment of Neuropathic Pain (2010)
- EFNS: Guidelines on Neurostimulation Therapy for Neuropathic Pain (2007)
Guidelines
- AAN: The Utility of EEG Theta/Beta Power Ratio in ADHD Diagnosis (2016)
- ICSI: Attention Deficit Hyperactivity Disorder in Primary Care for School-Age Children and Adolescents (2014)
- BAP:Evidence-based Guidelines for the Pharmacological Management of Attention Deficit Hyperactivity Disorder: An Update (2014)
- AACAP: Practice Parameter for the Assessment and Treatment of Children and Adolescents with Autism Spectrum Disorder (2013)
- BAP: Evidence Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addiction and Comorbidity: An Update (2012)
- WFSBP: Treatment of Substance Use and Related Disorders; Opioid Dependence (2011)
- NICE: Borderline Personality Disorder Treatment and Management (2009)
- SIGN: Management of ADHD in Children and Young People (2009)
- NICE: Diagnosis and Management of ADHD in Children Young People and Adults (2008)
- WFSBP: Guidelines for Biological Treatment of Personality Disorders (2007)
- APA: Substance Use Disorders: Practice Guidelines (2007)
- APA: Borderline Personality Disorder: Practice Guidelines (2005)
- APA: Suicidal Behaviour: Practice Guidelines (2003)
Our Publications
Patient Education
Clinical Tools
Guidelines
- WFSBP: Acute Treatment of Schizophrenia: (2014)
- NICE: Psychosis and Schizophrenia in Adults: Treatment and Management (2014)
- WFSBP: Long-term Treatment of Schizophrenia and Management of Antipsychotic- Induced Side Effects (2013)
- AACAP: Practice Parameter on the Assessment and Treatment of Children and Adolescents with Schizophrenia (2013)
- WFSBP: Acute Treatment of Schizophrenia and the Management of Treatment Resistance (2012)
- AACAP: Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents (2011)
- BAP: Evidence-based Guidelines for the Pharmacological Treatment of Schizophrenia (2010)
- APA: Practice Guidelines for Schizophrenia (2009)
- AACAP: Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents (2009)
Webcasts
Conference Proceedings
Patient Education
Guidelines
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke - An Update (2019)
- AHA/ASA: Early Management of Patients with Acute Ischemic Stroke (2018)
- Consensus on Pregnancy, Hormonal Treatment for Infertility, Contraception and Menopause in Women after Ischemic Stroke (2017)
- AHA/ASA: Management of Post-stroke Depression (2016)
- AHA/ASA: Prevention of Stroke in Patients with Silent Cerebrovascular Disease (2016)
- AHA: Implementation of Telehealth in Cardiovascular and Stroke Care (2016)
- AHA/ASA: Telemedicine Quality and Outcomes in Stroke-A Scientific Statement (2016)
- AHA/ASA: Palliative and End-of-Life Care in Stroke (2016)
- AHA/ASA: Palliative Care in Cardiovascular Disease and Stroke-Scientific Statement (2016)
- AHA/ASA: Adult Stroke Rehabilitation and Recovery (2016)
- AHA/ASA: Guidelines for the Management of Patients with Unruptured Intracranial Aneurysms (2015)
- AHA/ASA: Guidelines for the Management of Spontaneous Intracerebral Haemorrhage (2015)
- AHA/ASA: Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment (2015)
- AHA/ASA: Management of Cerebral and Cerebellar Infarction with Swelling (2014)
- AHA/ASA: Guidelines for the Primary Prevention of Stroke (2014)
- AHA/ASA: Physical Activity and Exercise Recommendations for Stroke Survivors (2014)
- AHA/ASA: Guidelines for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack (2014)
- AAN: Guidelines for the Prevention of Stroke in Women(2014)
- AAN: Periprocedural Management of Antithrombotic Medications in Patients with Ischemic Cerebrovascular Disease (2013)
- AHA/ASA: Guidelines for the Early Management of Adults with Ischemic Stroke (2007)
- AHA/ASA: Guidelines for Prevention of Stroke in Patients with Ischemic Stroke or Transient Ischemic Attack (2006)